Incyte Corp. (NASDAQ: INCY) is 0.27% higher on its value in year-to-date trading and has touched a low of $50.27 and a high of $70.36 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INCY stock was last observed hovering at around $64.33 in the last trading session, with the day’s loss setting it -1.37%.
Currently trading at $62.96, the stock is -0.76% and -0.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.3 million and changing -2.13% at the moment leaves the stock 5.94% off its SMA200. INCY registered -0.51% loss for a year compared to 6-month gain of 6.24%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.76% loss in the last 1 month and extending the period to 3 months gives it a 6.66%, and is -4.08% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.73% over the week and 2.51% over the month.
Incyte Corp. (INCY) has around 2524 employees, a market worth around $12.13B and $3.86B in sales. Current P/E ratio is 177.40 and Fwd P/E is 11.23. Profit margin for the company is 2.52%. Distance from 52-week low is 25.24% and -10.52% from its 52-week high. The company has generated returns on investments over the last 12 months (3.22%).
The EPS is expected to shrink by -55.04% this year
930.0 institutions hold shares in Incyte Corp. (INCY), with institutional investors hold 108.15% of the company’s shares. The shares outstanding are 224.29M, and float is at 190.32M with Short Float at 6.18%. Institutions hold 105.98% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 30.74 million shares valued at $1.86 billion. The investor’s holdings represent 13.693 of the INCY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 21.36 million shares valued at $1.29 billion to account for 9.5135 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 20.38 million shares representing 9.0766 and valued at over $1.24 billion, while DODGE & COX holds 6.8064 of the shares totaling 15.28 million with a market value of $926.23 million.
Incyte Corp. (INCY) Insider Activity
The most recent transaction is an insider sale by Stein Steven H, the company’s EVP & Chief Medical Officer. SEC filings show that Stein Steven H sold 11,608 shares of the company’s common stock on Aug 12 ’24 at a price of $60.63 per share for a total of $0.7 million. Following the sale, the insider now owns 90011.0 shares.
Still, SEC filings show that on Jul 25 ’24, Iyengar Vijay K (EVP, GMAPPS) disposed off 15,571 shares at an average price of $70.00 for $1.09 million. The insider now directly holds 36,701 shares of Incyte Corp. (INCY).
